» Articles » PMID: 38572008

Early Predictors of Intensive Care Unit Admission Among COVID-19 Patients in Qatar

Abstract

Background: COVID-19 is associated with significant morbidity and mortality. This study aimed to explore the early predictors of intensive care unit (ICU) admission among patients with COVID-19.

Methods: This was a case-control study of adult patients with confirmed COVID-19. Cases were defined as patients admitted to ICU during the period February 29-May 29, 2020. For each case enrolled, one control was matched by age and gender.

Results: A total of 1,560 patients with confirmed COVID-19 were included. Each group included 780 patients with a predominant male gender (89.7%) and a median age of 49 years (interquartile range = 18). Predictors independently associated with ICU admission were cardiovascular disease (adjusted odds ratio (aOR) = 1.64, 95% confidence interval (CI): 1.16-2.32, = 0.005), diabetes (aOR = 1.52, 95% CI: 1.08-2.13, = 0.016), obesity (aOR = 1.46, 95% CI: 1.03-2.08, = 0.034), lymphopenia (aOR = 2.69, 95% CI: 1.80-4.02, < 0.001), high AST (aOR = 2.59, 95% CI: 1.53-4.36, < 0.001), high ferritin (aOR = 1.96, 95% CI: 1.40-2.74, < 0.001), high CRP (aOR = 4.09, 95% CI: 2.81-5.96, < 0.001), and dyspnea (aOR = 2.50, 95% CI: 1.77-3.54, < 0.001).

Conclusion: Having cardiovascular disease, diabetes, obesity, lymphopenia, dyspnea, and increased AST, ferritin, and CRP were independent predictors for ICU admission in patients with COVID-19.

Citing Articles

The involvement of circulating miR-146a and miR-27a in patients with atherosclerotic cardiovascular disease after SARS-CoV-2 infection.

Zhou J, Wei C, Li G, He W, Song M, Liu X Clin Cardiol. 2024; 47(6):e24274.

PMID: 38884329 PMC: 11181128. DOI: 10.1002/clc.24274.


Adding colchicine to tocilizumab in hospitalized patients with severe COVID-19 pneumonia: An open-label randomized controlled trial.

Rahhal A, Najim M, Aljundi A, Mahfouz A, Alyafei S, Awaisu A Medicine (Baltimore). 2022; 101(39):e30618.

PMID: 36181009 PMC: 9524530. DOI: 10.1097/MD.0000000000030843.


COVID-19 Vaccination in Cancer Patients: A Review Article.

Mekkawi R, Elkattan B, Shablak A, Bakr M, Yassin M, Omar N Cancer Control. 2022; 29:10732748221106266.

PMID: 36066031 PMC: 9459453. DOI: 10.1177/10732748221106266.

References
1.
Guan W, Ni Z, Hu Y, Liang W, Ou C, He J . Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020; 382(18):1708-1720. PMC: 7092819. DOI: 10.1056/NEJMoa2002032. View

2.
Bolondi G, Russo E, Gamberini E, Circelli A, Meca M, Brogi E . Iron metabolism and lymphocyte characterisation during Covid-19 infection in ICU patients: an observational cohort study. World J Emerg Surg. 2020; 15(1):41. PMC: 7324776. DOI: 10.1186/s13017-020-00323-2. View

3.
Omrani A, Almaslamani M, Daghfal J, Alattar R, Elgara M, Shaar S . The first consecutive 5000 patients with Coronavirus Disease 2019 from Qatar; a nation-wide cohort study. BMC Infect Dis. 2020; 20(1):777. PMC: 7570422. DOI: 10.1186/s12879-020-05511-8. View

4.
Foldi M, Farkas N, Kiss S, Zadori N, Vancsa S, Szako L . Obesity is a risk factor for developing critical condition in COVID-19 patients: A systematic review and meta-analysis. Obes Rev. 2020; 21(10):e13095. PMC: 7404429. DOI: 10.1111/obr.13095. View

5.
Ma Y, Xu Q, Wang F, Ma X, Wang X, Zhang X . Characteristics of asymptomatic patients with SARS-CoV-2 infection in Jinan, China. Microbes Infect. 2020; 22(4-5):212-217. PMC: 7204664. DOI: 10.1016/j.micinf.2020.04.011. View